[Transperineal ultrasonic therapy for chronic prostatitis]

Area of Science:

• Urology
• Medical Technology
• Clinical Research

Context:

• Chronic prostatitis (CP) affects a significant patient population, often leading to debilitating symptoms.
• Current treatment options for CP may have limitations in efficacy or tolerability.

Purpose:

• To evaluate the clinical efficacy and safety of transperineal ultrasonic therapy for chronic prostatitis (CP).
• To compare outcomes between transperineal ultrasound treatment and a sham procedure using the NIH-CPSI score and prostate fluid analysis.

Summary:

• A randomized, double-blind, multi-centered trial involving 96 CP patients compared transperineal ultrasound therapy (Group A) with a sham procedure (Group B).
• Group A demonstrated a significantly higher total effectiveness rate (70.83%) versus Group B (25%, P < 0.01).
• Significant improvements in prostate pain, urinary symptoms, and quality of life (NIH-CPSI scores) were observed in Group A post-treatment compared to baseline and Group B.

Impact:

• Transperineal ultrasonic therapy is highly effective for CP, with notable benefits in pain relief.
• The therapy is safe, easy to operate, and well-accepted by patients, suggesting potential for broader clinical application.